10x Genomics Inc - Ordinary Shares - Class A
TXG
Market Cap$1.06B
Close$
$42.06
361.7% upside
Current Fair Value
361.7% upsideUndervalued by 361.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.06 Billion |
|---|---|
| Enterprise Value | $792.75 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.52 |
| Beta | 1.94 |
| Outstanding Shares | 122,606,091 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.44 |
|---|---|
| PEG | 17.43 |
| Price to Sales | 1.82 |
| Price to Book Ratio | 1.82 |
| Enterprise Value to Revenue | 1.27 |
| Enterprise Value to EBIT | -4.36 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About 10x Genomics Inc
CEO: Serge Saxonov